Westmount Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $339K | Sell |
13,991
-907
| -6% | -$22K | 0.09% | 171 |
|
|
2025
Q1 | $378K | Buy |
14,898
+7
| +0% | +$177 | 0.12% | 152 |
|
|
2024
Q4 | $395K | Sell |
14,891
-1,643
| -10% | -$43.6K | 0.12% | 136 |
|
|
2024
Q3 | $478K | Sell |
16,534
-728
| -4% | -$21.1K | 0.14% | 119 |
|
|
2024
Q2 | $487K | Sell |
17,262
-1,313
| -7% | -$37.1K | 0.16% | 113 |
|
|
2024
Q1 | $515K | Buy |
18,575
+1,658
| +10% | +$46K | 0.19% | 110 |
|
|
2023
Q4 | $487K | Sell |
16,917
-1,586
| -9% | -$45.7K | 0.2% | 105 |
|
|
2023
Q3 | $614K | Sell |
18,503
-799
| -4% | -$26.5K | 0.27% | 84 |
|
|
2023
Q2 | $708K | Buy |
19,302
+46
| +0.2% | +$1.69K | 0.31% | 71 |
|
|
2023
Q1 | $786K | Sell |
19,256
-1,250
| -6% | -$51K | 0.36% | 61 |
|
|
2022
Q4 | $1.05M | Buy |
+20,506
| New | +$1.05M | 0.55% | 38 |
|